Waku

4937.TTSE GROWTHChemicals

Filed as Waqoo Inc. (2022-08–2026-05)

Key numbers · FY ended 2025-09

Revenue¥2.0bn+0.9% YoY Operating income¥151m+169.0% YoY Net income (owners)¥44m—Total assets¥3.2bn+2.1% YoY EPS (basic)¥12.32+344.9% YoY

Full financial history and reports →

Stock price4937 · View chart ↗

Open the price chart on TradingView.

Latest filings

Mon, Apr 27 · JST1 filing

16:435% STAKEWaku · AIKAWA YOSHIYUKI + 1 joint holder · 32.90% → 37.22%+4.32pp

Thu, Dec 25 · JST1 filing

15:435% STAKEWaku · SBC Medical Group Co., Ltd. + 1 joint holder · 52.81% → 52.81%

Fri, Dec 19 · JST2 filings

13:485% STAKEWaku · AIKAWA YOSHIYUKI + 1 joint holder · 37.08% → 52.81%+15.73pp 11:565% STAKEWaku · Inoue Hiroki + 1 joint holder · 17.32% → 15.02%−2.30pp

Mon, Dec 15 · JST1 filing

13:09TOBWaqoo · SBC Medical Group Co., Ltd. reports tender offer result for Waqoo Inc.

All filings →

Major holders (5%+) · 4

Holder	Stake	Change	Filed
AIKAWA YOSHIYUKI	27.43%	+0.11pp	2026-04-27
SBC MEDICAL GROUP Inc.	9.80%	+0.04pp	2026-04-27
Inoue Hiroki	9.52%	-1.16pp	2025-12-19
M&M Inc.	5.50%	-1.14pp	2025-12-19

Each holder's own ratio from its most recent large-shareholding report.